SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Kosan BioSciences -- KOSN

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (290)6/23/2003 8:01:39 PM
From: keokalani'nui  Read Replies (1) of 933
 
This is cut and pasted by me. For the actual language, go to Edgar:

sec.gov

SKI hereby grants to LICENSEE, and LICENSEE hereby accepts from SKI, a worldwide, exclusive license, with the right to grant sublicenses, under the SKI PATENT RIGHTS and SKI KNOW-HOW, to make, USE, and develop any EPOTHILONE claimed in SKI PATENT RIGHTS, and, to make, have made, USE, import, offer for SALE, SELL, and have SOLD any pharmaceutical product containing any EPOTHILONE claimed in SKI PATENT RIGHTS that is selected for DEVELOPMENT and/or marketing by Licensee in the FIELD.

"SKI PATENT RIGHTS" shall mean (i) the patents and patent applications identified in Exhibit B hereof, and (ii) other patents or patent applications to the extent they disclose and claim inventions made by SKI in performance of the RESEARCH PROGRAM, and (iii) any other claims in existing or future patents or patent applications covering the manufacture, USE, or SALE of any pharmaceutical product containing any EPOTHILONE claimed in SKI PATENT RIGHTS that is selected for DEVELOPMENT and/or marketing by LICENSEE for the treatment of cancer to the extent such patents or patent applications claim inventions made by SKI during the RESEARCH TERM of this AGREEMENT.

EXHIBIT A

RESEARCH PLAN

25 AUGUST 2000

This Research Plan describes the activities contemplated by the

parties as of the Effective Date of the Research Collaboration and License

Agreement. These activities include:

<TABLE>
<S> <C>

[**]

</TABLE>

Confidential Information
1

[**] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED
SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED
WITH RESPECT TO THE OMITTED PORTIONS.

EXHIBIT B

SKI PATENT RIGHTS

SERIAL NUMBER FILING DATE STATUS
---------------------------------------------------------------------------------------------------
<S> <C> <C>

[**]
</TABLE>

[**] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED
SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED
WITH RESPECT TO THE OMITTED PORTIONS.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext